Guardant Health Inc (GH)

Cost of Revenue

$115.95M

Quarterly · Period ending: · USD

GH logo

GH Cost of Revenue

Latest reported$115.95M
GH Quarterly Cost of Revenue ($6.90M → $115.95M)
High-resolution chart · PNG

GH cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Guardant Health Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
115,949,000
104,919,000
99,492,000
93,587,000
81,205,000
74,723,000
77,593,000
74,489,000
72,421,000
65,296,000
62,517,000
57,614,000
53,848,000
53,073,000
47,121,000
40,496,000
36,727,000
31,981,000
33,422,000
30,816,000
29,927,000
28,747,000
28,407,000
21,187,000
22,435,000
20,506,000
21,838,000
18,514,000
16,833,000
13,535,000
13,947,000
10,051,000
9,959,000
9,253,000
9,148,000
8,661,000
7,435,000
6,904,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.